Pronota Raises Additional $1.8M in Financing | GenomeWeb

a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) —Biomarker developer Pronota has raised an additional €1.5million ($1.8 million) for a total of €7.9 million in its Series B financing round, the company said yesterday.

The Ghent, Belgium-based firm plans to use the funds raised in the round to develop technologies for cardio-renal, pre-eclampsia, sepsis, and ovarian cancer diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.